Argenx, Zai Lab announce approval of VYVGART Hytrulo in China
(ARGX) and Zai Lab Limited (ZLAB) announced that China’s National Medical Products Administration, NMPA, approved the supplemental ...
Argenx and Zai Lab’s CIDP Drug Approved in China
Argenx Se (ARGX) has released an update. Argenx SE and Zai Lab Limited have announced that their drug VYVGART Hytrulo has received approval ...
Argenx upgraded at Wolfe on myasthenia gravis dominance
Argenx (ARGX) stock upgraded at Wolfe Research citing dominance in myasthenia gravis market and profitability outlook. Read ...
Business Wire2d
Zai Lab and argenx Announce Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in China
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) and argenx (Euronext & Nasdaq: ARGX) today announced that China’s National Medical Products Administrat ...
Hosted on MSN23h
Zai Lab and argenx announce NMPA approval for sBLA for VYVGART Hytrulo
Zai Lab and argenx have announced receipt of approval from the National Medical Products Administration (NMPA) of China for ...
pharmaphorum3d
FDA clears Argenx’ Vyvgart Hytrulo for rare disease CIDP
Netherlands biotech Argenx has a second FDA approval for its FcRn inhibitor Vyvgart Hytrulo, adding a new indication in chronic inflammatory demyelinating polyneuropathy (CIDP) for a drug that it ...
MarketWatch1d
United States Steel Corp.
Gerdau S/A Ord-0.05% R$41.48B ...
7NEWS6d
Adelaide Crows unveil new-look logo as part of major brand shake-up
The Adelaide Crows have officially unveiled their new team logo despite the fact they were aware fan backlash ... “It’s like going from Windows 10 to Windows 98,” one fan said on X (formerly Twitter).
Investing22h
argenx NV ADR (ARGX)
On Tuesday, Wolfe Research upgraded argenx SE (NASDAQ: ARGX) stock from Peerperform to Outperform with a price target of $697.00. The firm anticipates a positive trajectory for ...